Coherus Oncology, Inc. (FRA:8C5)
Germany · Delayed Price · Currency is EUR 1.440
+0.075 (5.46%)
At close: Feb 20, 2026
36.32% (1Y)
| Market Cap | 206.80M +55.8% |
| Revenue (ttm) | 236.71M +152.1% |
| Net Income | 132.08M |
| EPS | 1.14 |
| Shares Out | n/a |
| PE Ratio | 1.57 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 570 |
| Open | 1.440 |
| Previous Close | 1.365 |
| Day's Range | 1.440 - 1.440 |
| 52-Week Range | 0.608 - 2.188 |
| Beta | n/a |
| RSI | 44.88 |
| Earnings Date | Mar 9, 2026 |